Januvia
Product Images NDC 50090-5547

4 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Januvia (NDC 50090-5547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Sitagliptin Chemical Structure (Januvia 01)

Image Of Sitagliptin Chemical Structure (Januvia 01)
Chemical structure of Januvia (sitagliptin) phosphate monohydrate, showing fluorinated aromatic ring and trifluoromethyl-substituted triazolopyrazine moiety.*
FDA Label Image

Image Of Figure 1 (Januvia 02)

Image Of Figure 1 (Januvia 02)
A line graph depicting the least squares mean change from baseline over 24 weeks for different treatments, including placebo, sitagliptin 100 mg once daily, metformin 500 mg twice daily, metformin 1000 mg twice daily, sitagliptin 50 mg twice daily with metformin 500 mg twice daily, and sitagliptin 50 mg twice daily with metformin 1000 mg twice daily. The y-axis shows mean change values, and the x-axis represents weeks from 0 to 24.*
FDA Label Image

Image Of Figure 2 (Januvia 03)

Image Of Figure 2 (Januvia 03)
A line graph depicting the least squares mean change from baseline over 52 weeks. The x-axis represents weeks, ranging from 0 to 52, and the y-axis represents the least squares mean change from baseline, ranging from 0.0 to -1.5. Two lines compare Januvia 100 mg (solid diamonds) and Glipizide (open circles), showing a similar trend of decreasing values that plateau between weeks 12 and 30, followed by a gradual increase towards week 52.*
FDA Label Image

Label Image (Lbl500905547)

Label Image (Lbl500905547)
JANUVIA 25 mg film-coated tablets packaging label showing the proprietary name JANUVIA with the active ingredient sitagliptin. The label includes dosage strength of 25 mg, storage instructions to keep between 68 to 77 degrees Fahrenheit, and a quantity of 30 tablets. The labeler is A-S Medication Solutions, with a visible product NDC of 50090-5547-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.